Recent studies have found that the development of a hybrid closed-loop system reduces the burden of diabetes management in patients with T1D, enables glucose-responsive insulin delivery, and protects against hypoglycemia, resulting in improved glycemic control (49–51). Here, INS is linked to Hypoglycemia.